Legal Opinion
Takeda Pharmaceuticals U.S.A., Inc. v. West-Ward Pharmaceutical Corp.
District Court, D. Delaware
Decided May 18, 2016No. Civ. No. 14-1268-SLRPublishedCited by 1 opinion
1Opinion of the Court
MEMORANDUM OPINION
ROBINSON, District Judge
I. INTRODUCTION
On October 3, 2014, Takeda Pharmaceuticals U.S.A., Inc. (“Takeda”) filed suit against West-Ward Pharmaceutical Corporation, Hikma Americas Inc., and Hikma Pharmaceuticals' PLC (collectively, “Hik-ma”), asserting induced infringement of five patents under 35 U.S.C. § 271(b).1 (D.I. 1) Takeda is the owner of the asserted patents, which contain one or more claims covering methods of use of Takeda’s colchicine product, Colerys®. (D.I. 109 at 8) Colerys® is used primarily for preventing and treating gout flares. (Id. at 5)
Hikma has launched…
2Cases cited28 opinions
- Ashcroft v. IqbalSupreme Court of the United States · 2009
- Bell Atlantic Corp. v. TwomblySupreme Court of the United States · 2007
- Erickson v. PardusSupreme Court of the United States · 2007
- Phillips v. County of AlleghenyCourt of Appeals for the Third Circuit · 2008
- Fowler v. UPMC SHADYSIDECourt of Appeals for the Third Circuit · 2009
23 more not listed; retrieve them via the Exa API.
3Cited by1 opinion
- Takeda Pharmaceuticals U.S.A., Inc. v. BurwellCourt of Appeals for the D.C. Circuit · 2016